NCT03632239View on ClinicalTrials.gov

Reverse Phenotyping Core

Enrolling by invitationOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 23, 2020

Primary Completion Date

June 1, 2028

Study Completion Date

December 29, 2028

Conditions

Harboring of Unexpected Genetic Variant

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Human Genome Research Institute (NHGRI)

NIH